Here is Matt Lowdon‘s weekly update of deals covering news across medical technology and biotech. This week, headlines include record VC fund raises, endovascular technology, molecular glues, and more. Congratulations to all involved and let me know if we missed anything.
🔔 Paris-based private equity fund JEITO has hailed the $1.2 billion it has secured as the “largest raise ever achieved” by an independent biopharma-focused European fund.
đź””Lucida Medical, a Cambridge-based startup using AI to support the cancer diagnostic process has raised ÂŁ8.7m in a funding round that included Macmillan Cancer Support.
🔔Oricell Therapeutics has now raised over $110 million in its final funding round before the Chinese CAR-T therapy biotech seeks to go public.
đź””California-based medtech E2 – Endovascular Engineering has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment.
đź””Early-stage impact VC Eka Ventures has announced its ÂŁ80m second fund to back UK-founded startups in the health, wellbeing and sustainability spaces.
🔔Gilead Sciences has tucked another drug candidate into a pipeline bulging from a recent deal flurry, paying $45 million to exercise its option on Kymera Therapeutics’ preclinical anticancer molecular glue degrader.
🔔Amid chronic under-investments in new antibacterial weapons, Basilea Pharmaceutica has secured an additional US$6 million from CARB‑X to fund the first‑in‑human Phase I trial of a novel Gram‑negative antibiotic
🔔French Generare, founded in 2023, is positioning itself at the intersection of synthetic biology and artificial intelligence by tackling what many in the sector now see as a fundamental bottleneck: the lack of genuinely novel molecular data. It has raised €20m in Series A financing.
🔔neuroClues, a French-Belgian MedTech startup empowering clinicians with biomarkers allowing them to identify neurological disorders years before visible symptoms, has raised a €10 million Series A.
🔔Beacon Biosignals raises $97m to advance EEG headband. Beacon’s Waveband monitors EEG signals to evaluate brain health and identify neurobiomarkers to stratify patient populations for neurological clinical trials.
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.